CORT
Corcept Therapeutics Incorporated
NASDAQ: CORT · HEALTHCARE · BIOTECHNOLOGY
$46.59
-0.06% today
Updated 2026-04-29
Market cap
$5.00B
P/E ratio
56.82
P/S ratio
6.57x
EPS (TTM)
$0.82
Dividend yield
—
52W range
$29 – $91
Volume
1.8M
Corcept Therapeutics Incorporated (CORT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $294000.00 | $482000.00 | $209000.00 | $29000.00 | — | $0.00 | $3.31M | $10.36M | $26.55M | $50.29M | $81.32M | $159.20M | $251.25M | $306.49M | $353.87M | $365.98M | $401.86M | $482.38M | $675.04M | $761.41M |
| Revenue growth (YoY) | — | +63.9% | -56.6% | -86.1% | -100.0% | — | — | +213.2% | +156.4% | +89.4% | +61.7% | +95.8% | +57.8% | +22.0% | +15.5% | +3.4% | +9.8% | +20.0% | +39.9% | +12.8% |
| Cost of revenue | $25.86M | $12.71M | $19.89M | $20.27M | — | $0.00 | $91000.00 | $143000.00 | $882000.00 | $1.36M | $2.06M | $3.55M | $5.21M | $5.50M | $5.58M | $5.28M | $5.38M | $6.48M | $10.88M | $12.98M |
| Gross profit | $294000.00 | $482000.00 | $209000.00 | $29000.00 | — | $0.00 | $3.22M | $10.21M | $25.67M | $48.92M | $79.26M | $155.65M | $246.03M | $300.98M | $348.29M | $360.70M | $396.47M | $475.89M | $664.16M | $748.43M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | — | — | 97.2% | 98.6% | 96.7% | 97.3% | 97.5% | 97.8% | 97.9% | 98.2% | 98.4% | 98.6% | 98.7% | 98.7% | 98.4% | 98.3% |
| R&D | $20.83M | $7.86M | $14.15M | $14.40M | $18.95M | $21.00M | $14.07M | $20.47M | $18.37M | $15.42M | $23.84M | $40.38M | $75.25M | $89.02M | $114.76M | $113.86M | $130.99M | $184.35M | $246.89M | $254.91M |
| SG&A | $5.04M | $4.87M | $5.75M | $5.88M | $8.49M | $11.33M | $25.41M | $31.24M | $34.92M | $36.95M | $45.24M | $62.42M | $81.29M | $100.36M | $105.33M | $122.36M | $152.85M | $184.26M | $280.32M | $448.73M |
| Operating income | $-25.58M | $-12.24M | $-19.69M | $-20.25M | $-27.44M | $-32.33M | $-36.27M | $-41.50M | $-27.62M | $-3.44M | $10.18M | $52.85M | $89.50M | $111.61M | $128.20M | $124.48M | $112.63M | $107.28M | $136.95M | $44.80M |
| Operating margin | -8701.4% | -2540.5% | -9420.6% | -69827.6% | — | — | -1096.8% | -400.7% | -104.0% | -6.8% | 12.5% | 33.2% | 35.6% | 36.4% | 36.2% | 34.0% | 28.0% | 22.2% | 20.3% | 5.9% |
| EBITDA | $-25.58M | $-12.24M | $-19.69M | $-20.25M | $-25.96M | $-32.35M | $-36.24M | $-41.42M | $-27.48M | $-3.29M | $10.27M | $52.96M | $89.73M | $113.78M | $130.44M | $127.54M | $115.60M | $108.32M | $138.29M | $68.35M |
| EBITDA margin | -8701.4% | -2540.5% | -9420.6% | -69827.6% | — | — | -1096.0% | -399.9% | -103.5% | -6.5% | 12.6% | 33.3% | 35.7% | 37.1% | 36.9% | 34.9% | 28.8% | 22.5% | 20.5% | 9.0% |
| EBIT | $-25.60M | $-12.26M | $-19.70M | $-20.26M | $-25.97M | $-32.35M | $-36.27M | $-41.50M | $-27.62M | $-3.44M | $10.18M | $52.85M | $89.50M | $111.61M | $128.20M | $124.48M | $112.63M | $107.28M | $136.95M | $66.46M |
| Interest expense | $0.00 | $0.00 | $944000.00 | $101000.00 | $1.50M | $3000.00 | $1.78M | $4.51M | $3.76M | $2.96M | $2.04M | $49000.00 | $2.66M | $5.07M | $5.64M | $3.60M | $3.56M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-24.87M | $-11.57M | $-20.06M | $-20.17M | $-25.97M | $-32.35M | $-38.05M | $-46.01M | $-31.38M | $-6.41M | $8.14M | $129.12M | $75.41M | $94.18M | $106.01M | $112.51M | $101.42M | $106.14M | $139.73M | $99.65M |
| Net income growth (YoY) | — | +53.5% | -73.3% | -0.5% | -28.8% | -24.6% | -17.6% | -20.9% | +31.8% | +79.6% | +227.0% | +1486.3% | -41.6% | +24.9% | +12.6% | +6.1% | -9.9% | +4.7% | +31.6% | -28.7% |
| Profit margin | -8460.2% | -2401.0% | -9598.6% | -69537.9% | — | — | -1150.5% | -444.3% | -118.2% | -12.7% | 10.0% | 81.1% | 30.0% | 30.7% | 30.0% | 30.7% | 25.2% | 22.0% | 20.7% | 13.1% |